pantoprazole has been researched along with Response Evaluation Criteria in Solid Tumors in 1 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Response Evaluation Criteria in Solid Tumors: An internationally recognized set of published rules used for evaluation of cancer treatment that define when tumors found in cancer patients improve, worsen, or remain stable during treatment. These criteria are based specifically on the response of the tumor(s) to treatment, and not on the overall health status of the patient resulting from treatment.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Blood samples were collected for pharmacokinetic studies." | 2.79 | A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicin. ( Bedard, PL; Brana, I; Chen, EX; Douglas, S; Haines, C; Lee, C; Ocana, A; Razak, AR; Siu, LL; Tannock, IF; Wang, L, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brana, I | 1 |
| Ocana, A | 1 |
| Chen, EX | 1 |
| Razak, AR | 1 |
| Haines, C | 1 |
| Lee, C | 1 |
| Douglas, S | 1 |
| Wang, L | 1 |
| Siu, LL | 1 |
| Tannock, IF | 1 |
| Bedard, PL | 1 |
1 trial available for pantoprazole and Response Evaluation Criteria in Solid Tumors
| Article | Year |
|---|---|
A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols | 2014 |